Treatment evolution and survival impact of consolidation therapies in mantle cell lymphoma: insights from an Asia-Pacific real-world registry - Summary - MDSpire

Treatment evolution and survival impact of consolidation therapies in mantle cell lymphoma: insights from an Asia-Pacific real-world registry

  • By

  • Hyungwoo Cho

  • Koji Kato

  • Jason Yongsheng Chan

  • Kim Dajung

  • Haiwen Huang

  • Qingqing Cai

  • Tongyu Lin

  • Udomsak Bunworasate

  • Sen-Mui Tan

  • Ka-Won Kang

  • Jae-Yong Kwak

  • Tsai-Yun Chen

  • Jeong-Ok Lee

  • Seong Hyun Jeong

  • Young Rok Do

  • Esther Chan

  • Hye Jin Kang

  • Hyeon-Seok Eom

  • Sung Yong Oh

  • Youngil Koh

  • Hyo Jung Kim

  • Se-Hyung Kim

  • Jong Ho Won

  • Young Hoon Park

  • Deok Hwan Yang

  • Soo Chin Ng

  • Jae-Cheol Jo

  • Hilman Tadjoedin

  • Anna Mira Lubis

  • Noorwati Sutandyo

  • Tsuyoshi Muta

  • Ken Takase

  • Dok Hyun Yoon

  • Won Seog Kim

  • May 29, 2026

  • 0 min

Share

Objective:

To delineate real-world treatment patterns, evaluate survival outcomes, and assess the impact of upfront ASCT and rituximab maintenance in newly diagnosed MCL patients across the APAC region.

Key Findings:
  • Include specific statistical values (e.g., hazard ratios) for clarity.
Interpretation:

Remove unsupported conclusions and editorial interpretations.

Limitations:
  • The study is retrospective and may be subject to selection bias.
  • Consolidation therapies were underutilized, with only 24.1% of ASCT-eligible patients undergoing transplantation.
Conclusion:

Remove unsupported claims and editorial interpretations.

Original Source(s)

Treatment evolution and survival impact of consolidation therapies in mantle cell lymphoma: insights from an Asia-Pacific real-world registry

  • by Hyungwoo Cho, Koji Kato, Jason Yongsheng Chan, Kim Dajung, Haiwen Huang, Qingqing Cai, Tongyu Lin, Udomsak Bunworasate, Sen-Mui Tan, Ka-Won Kang, Jae-Yong Kwak, Tsai-Yun Chen, Jeong-Ok Lee, Seong Hyun Jeong, Young Rok Do, Esther Chan, Hye Jin Kang, Hyeon-Seok Eom, Sung Yong Oh, Youngil Koh, Hyo Jung Kim, Se-Hyung Kim, Jong Ho Won, Young Hoon Park, Deok Hwan Yang, Soo Chin Ng, Jae-Cheol Jo, Hilman Tadjoedin, Anna Mira Lubis, Noorwati Sutandyo, Tsuyoshi Muta, Ken Takase, Dok Hyun Yoon, Won Seog Kim

  • May 29, 2026

Related Content

Ultra-high-sensitivity next-generation sequencing–based MRD predicts outcome in intensively treated older patients with acute myeloid leukemia: results from the ALFA-1200 cohort

Case Report: Synovial sarcoma with diffuse myxoid stroma and complete absence of epithelial differentiation in the extremity

Trametinib as second-line therapy for advanced KRAS G12C-mutant non-small cell lung cancer: a single-center clinical analysis of 20 cases